1 domain / 2 areas / 1 specialization
Evercore
Data updated
Evercore is a publicly traded global independent investment banking advisory firm, not a venture fund or direct psychedelic investor. It was founded in 1995 and is headquartered in New York, United States, with offices and affiliate offices across major financial centers in North America, Europe, the Middle East, and Asia.
In the psychedelic ecosystem, Evercore’s relevance is mainly as a capital markets and strategic advisory firm rather than a specialist life-sciences investor. Its healthcare and biotech coverage, private capital markets, and public-company advisory work can make it relevant to psychedelic companies seeking M&A advice, financing, or public-market transactions.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
Evercore is an independent investment banking firm with broad public-market and private-capital advisory capabilities, including M&A, shareholder advisory, equity capital markets, private placements, PIPEs, and private capital markets work. The firm has specific healthcare and biotech coverage within its advisory platform, but there is no public indication that it maintains a dedicated psychedelic investment strategy or direct psychedelic portfolio.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 1995
- HQ
- New York, NY 10055, United States
- Website
- Visit